GW Henssler & Associates’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $202K | Sell |
703
-7
| -1% | -$2.01K | 0.01% | 177 |
|
|
2025
Q1 | $219K | Sell |
710
-1
| -0.1% | -$308 | 0.01% | 161 |
|
|
2024
Q4 | $255K | Hold |
711
| – | – | 0.01% | 139 |
|
|
2024
Q3 | $255K | Buy |
+711
| New | +$255K | 0.01% | 143 |
|
|
2023
Q3 | – | Sell |
-1,324
| Closed | -$292K | – | 270 |
|
|
2023
Q2 | $292K | Hold |
1,324
| – | – | 0.02% | 151 |
|
|
2023
Q1 | $297K | Buy |
1,324
+12
| +0.9% | +$2.69K | 0.02% | 170 |
|
|
2022
Q4 | $365K | Hold |
1,312
| – | – | 0.03% | 132 |
|
|
2022
Q3 | $275K | Sell |
1,312
-182
| -12% | -$38.1K | 0.02% | 159 |
|
|
2022
Q2 | $352K | Sell |
1,494
-1,826
| -55% | -$430K | 0.03% | 128 |
|
|
2022
Q1 | $596K | Buy |
3,320
+5
| +0.2% | +$898 | 0.04% | 104 |
|
|
2021
Q4 | $716K | Buy |
+3,315
| New | +$716K | 0.05% | 108 |
|
|
2021
Q3 | – | Sell |
-3,055
| Closed | -$548K | – | 216 |
|
|
2021
Q2 | $548K | Buy |
3,055
+73
| +2% | +$13.1K | 0.04% | 116 |
|
|
2021
Q1 | $499K | Hold |
2,982
| – | – | 0.04% | 124 |
|
|
2020
Q4 | $453K | Buy |
2,982
+16
| +0.5% | +$2.43K | 0.03% | 129 |
|
|
2020
Q3 | $300K | Buy |
2,966
+105
| +4% | +$10.6K | 0.03% | 153 |
|
|
2020
Q2 | $346K | Sell |
2,861
-1,488
| -34% | -$180K | 0.03% | 123 |
|
|
2020
Q1 | $412K | Sell |
4,349
-255
| -6% | -$24.2K | 0.04% | 114 |
|
|
2019
Q4 | $406K | Buy |
4,604
+804
| +21% | +$70.9K | 0.03% | 160 |
|
|
2019
Q3 | $303K | Sell |
3,800
-600
| -14% | -$47.8K | 0.03% | 178 |
|
|
2019
Q2 | $343K | Buy |
4,400
+928
| +27% | +$72.3K | 0.03% | 173 |
|
|
2019
Q1 | $408K | Buy |
+3,472
| New | +$408K | 0.04% | 152 |
|
|
2015
Q3 | – | Sell |
-1,314
| Closed | -$229K | – | 174 |
|
|
2015
Q2 | $229K | Sell |
1,314
-161
| -11% | -$28.1K | 0.02% | 145 |
|
|
2015
Q1 | $254K | Buy |
+1,475
| New | +$254K | 0.03% | 151 |
|